Leif Bjermer
11 – 20 of 362
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
(
- Contribution to journal › Article
-
Mark
Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation
(
- Contribution to journal › Article
-
Mark
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024) In Journal of Allergy and Clinical Immunology: In Practice(
- Contribution to journal › Article
- 2023
-
Mark
Eosinophils and tissue remodeling : Relevance to airway disease
(
- Contribution to journal › Scientific review
-
Mark
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
(
- Contribution to journal › Article
-
Mark
EUFOREA pocket guide on the diagnosis and management of asthma : An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients
(
- Contribution to journal › Article
-
Mark
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
(
- Contribution to journal › Article
-
Mark
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
(
- Contribution to journal › Article
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
(
- Contribution to journal › Article
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
(
- Contribution to journal › Letter